ReviewVascular health and risk management2016
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab.
Dirk J Blom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ReviewVascular health and risk management2016
Dirk J Blom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.